Visions - Fall 2007 - 16

Continued According to Bruce Truman, Senior Director of Sales and Customer Service at SVP, “Our early market research clearly showed that there was a need for a new flea and tick product in this nearly $1 billion category. Pet owner’s needs were not being met for a variety of reasons such as veterinary price concerns, compliance issues and the problem that products which once were only available at the veterinary clinics were now available for purchase on the internet and in various retail outlets therefore undercutting the veterinary clinic.” SVP was founded on a strong belief in the veterinary profession and that products which help prevent the transmission of vector-borne diseases should be in their hands. “The story that we like to tell on the sales call is about actually partnering with the doctor. No company out there is trying to embrace these clinics the way we are especially in the area of diversion of products to online or over-the-counter outlets which causes veterinarians to lose a significant amount of business to alternative sources”, explains Byron Uppercue, Eastern Regional Sales Manager at SVP. “We have many years of experience in the industry. As a company, we support the notion that the product should be in the hands of professionals so they can educate their patients on the correct use and benefits of the product.” So far the sales team has found doctors appreciate the new molecule, the new applicator, and Bloodhound technology. Mr. Truman added, “The product itself has advances that resonate with all customers. The team that developed the product are experts in the category and worked hard to make certain that all lessons learned from the development of past products were used to create Vectra 3D.” Looking to the future, SVP will also introduce a flea only product for cats, Vectra for Cats, which also includes the new molecule Dinotefuran. It will be available to veterinarians for purchase by early next year. SUMMIT VETPHARM INTRODUCES NEW VECTRA 3D™ FOR DOGS N ew Vectra 3D™ - the first of many exciting products from Summit VetPharm (SVP) – has officially been launched. The new monthly topical repels and kills fleas, ticks and mosquitoes for at least one month. SVP named the product Vectra because it protects against vectors of disease. The “3” represents three active ingredients: dinotefuran, permethrin, and pyriproxifen. The “D” stands for dogs. Only Vectra 3D provides so many dimensions in protection for dogs and so many options for veterinarians. One of the major improvements for dog owners is the product’s unique, patented applicator which features an elongated tip that makes it easy to apply to a dog’s skin through the haircoat. The rounded tip minimizes risk of skin abrasions and the easy-to-open applicator eliminates splash back and spilling while the contoured shape makes it easier to handle. With the one-piece applicator, there is no need to use scissors to open or remove a cap, making application fast and efficient, and at the same time, minimizing the potential of a choking hazard. • New - a novel, triple action formulation that parasites have never encountered. • Complete - kills fleas at all stages of development, four species of ticks, plus three species of mosquitoes. • Fast - kills 96% of adult fleas within 6 hours, up to 100% in 12 hours. • Repels and Kills Fleas, Ticks and Mosquitoes - three vectors that may transmit disease. • Lasting - provides a full month of protection. • Safety - gentle enough for puppies as young as 7 weeks. • Easy - an applicator so unique and easy-to-use, it’s patented. • Traceable – authenticity and veterinarian exclusivity is protected by Bloodhound™ Technology. If you have a pet, be sure to ask your veterinarian for Vectra 3D on your next visit. For more information on the product, please visit www.summitvetpharm.com 16 visions Fall 2007 Sumitomo Corporation of America

http://www.summitvetpharm.com

Visions - Fall 2007

Table of Contents for the Digital Edition of Visions - Fall 2007